The Trump Administration’s Response to the Drug Crisis, Part II

SUBCOMMITTEE CHAIRMAN CONNOLLY'S OPENING STATEMENT

PURPOSE

The hearing will examine ONDCP’s coordination of national drug control efforts, including the Administration’s response to the opioid crisis.  The hearing will also examine ONDCP’s implementation of the provisions of the SUPPORT for Patients and Communities Act that reauthorized the agency.

Witnesses

WITNESSES

The Honorable James W. Carroll Jr.
Director
Office of National Drug Control Policy

Triana McNeil
Acting Director, Homeland Security and Justice
Government Accountability Office

Karyl Thomas Rattay, M.D., M.S.
Director
Delaware Division of Public Health

Sheriff Wayne Ivey
Brevard County, Florida